Recurrent Head And Neck Cancer Clinical Trials

ReadTheTrial indexes 1 studies for Recurrent Head And Neck Cancer. The most common development stage is Phase 3 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Recurrent Head And Neck Cancer.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
100%

Trial Status Breakdown

Trials for Recurrent Head And Neck Cancer

A Phase 3 Open-Label, Randomized Study of PDS0101 and Pembrolizumab vs Pembrolizumab Alone in First-Line Treatment of Unresectable Recurrent and/or Metastatic HPV16+ Head and Neck Squamous Cell Carcinoma

NCT06790966 · ACTIVE NOT RECRUITING · Phase 3

Frequently Asked Questions

What clinical trials are available for Recurrent Head And Neck Cancer?

There are 1 clinical trials listed for Recurrent Head And Neck Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Recurrent Head And Neck Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Recurrent Head And Neck Cancer trials in?

Current Recurrent Head And Neck Cancer trials are distributed across: Phase 3 (1).

Find More Trials